Breast cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Treatment group: (1) Voluntary signing of informed consent; (2) Aged 18-80 years; (3) Women; (4) Patients with breast cancer diagnosed by pathology according to the ''Breast Cancer Diagnosis and Treatment Guidelines 2020'' designated by the Guidelines Working Committee of the Chinese Society of Clinical Oncology (CSCO); (5) Patients who completed postoperative adjuvant therapy; Good follow-up compliance; (6) Survival expectancy >=3 months; Good follow-up compliance; (7) Patients who need to receive milk prescription treatment according to the judgment of treating doctors. 2. Control group: (1) Voluntary signing of informed consent; (2) Aged 18-80 years; (3) Women; (4) Healthy people with no malignant tumor found by physical examination in recent 3 months.
Exclusion criteria
Exclusion criteria: 1. Complicated with other malignant tumors; 2. Participating in or about to participate in other clinical trials; 3. It is judged by the researcher that it is not suitable to participate in this study; 4. Pregnancy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Tumor autoantibody; | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood routine;Liver and kidney function;Urine examination;Fecal examination;Tumor markers;Electrocardiogram; | — |
Countries
China
Contacts
Foshan Hospital of TCM